About Enhancer
| Enhancer ID: | E_02871 |
| Species: | Homo sapiens |
| Position : | chr2:85750614-85811383   |
| Year: | 2016 |
| Title: | Chromatin interactions and candidate genes at ten prostate cancer risk loci. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 26979803 |
| Tissue: | prostate gland |
| Tissue Ontology ID: | UBERON:0002367 |
| Cell Source: | RWPE-1 |
| CVCL ID: | CVCL_3791 |
| Cell Type: | prostate epithelial cell |
| Experiment Type: | Chromatin interaction assay, TF binding assay, Gene expression assay |
| High Throughput Method: | Capture 3C-seq; ChIP-seq; RNA-seq; SNP genotyping array; 3C; eQTL analysis |
| Low Throughput Method: | 3C-qPCR; RT-qPCR |
About Target Gene
| Target gene : | CAPG |
About TF
| TF name : | CTCF |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| CTCF | Activation of anterior HOX genes in hindbrain development during early embryogenesis | reactome | 120 |
| CTCF | TGF_beta_Receptor | netpath | 220 |
Enhancer Associated Network
Overlapping Enhancers (hg19)
23 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02854 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02855 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02856 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02857 | chr2:85750614-85811383 | prostate gland | malignant cell | prostate cancer |
| E_02870 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02872 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02873 | chr2:85750614-85811383 | prostate gland | prostate epithelial cell | NA |
| E_02893 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02894 | chr2:85750614-85811383 | blood | NA | NA |
| E_02895 | chr2:85750614-85811383 | blood | NA | NA |
| E_02896 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02897 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02898 | chr2:85750614-85811383 | blood | NA | NA |
| E_02899 | chr2:85750614-85811383 | blood | NA | NA |
| E_02900 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02901 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02902 | chr2:85750614-85811383 | blood | NA | NA |
| E_02903 | chr2:85750614-85811383 | blood | NA | NA |
| E_02904 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02905 | chr2:85750614-85811383 | prostate gland | NA | NA |
| E_02906 | chr2:85750614-85811383 | blood | NA | NA |
| E_02907 | chr2:85750614-85811383 | blood | NA | NA |
| E_02908 | chr2:85750614-85811383 | prostate gland | NA | NA |
Expression of Target Genes for the Enhancer